Supplementary Figure S1 from A Phase Ib First-In-Patient Study Assessing the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ponsegromab in Participants with Cancer and Cachexia

• DOI: 10.1158/1078-0432.25124622.v1
• Publication Date: 2024-02-01T08:22:18Z
• Authors: Jeffrey Crawford; Roberto A. Calle; Susie M. Collins; Yan Weng; Shannon L. Lubacz...; Clare Buckeridge; Ellen Q. Wang; Magdalena A. Harr...; Anil Tarachandani; Michelle I. Rossulek; James H. Revkin

<p>Study design</p>